Aclarion Partners With PRIA Healthcare to Expand Reimbursement Path for AI Back Pain Platform

Aclarion, the healthcare SaaS platform, has launched a market access program with PRIA Healthcare as the company seeks broader reimbursement coverage and commercial adoption for its AI-powered Nociscan platform, which is designed to help physicians identify sources of chronic low back pain.

The partnership will focus on payer engagement, prior authorization support, appeals management, and reimbursement strategy as Aclarion works to expand patient access to Nociscan across the United States.

According to the company, Nociscan combines magnetic resonance spectroscopy (MRS), proprietary signal processing, biomarkers, and augmented intelligence algorithms to help physicians distinguish between painful and non-painful lumbar discs. The platform analyzes spectroscopy data collected during MRI scans and generates insights intended to support treatment planning and surgical decision-making.

The announcement comes as healthcare companies increasingly look to pair AI-driven diagnostics with evidence generation and reimbursement strategies that support long-term adoption. Similar efforts are underway in other areas of diagnostics where biomarker data and AI models are being used to support clinical decisions, including women's health and disease detection workflows.